Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2016-03-31 Report Publication Anno…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Communiqués de mise à disposition de documents / Modalités de mise à disposition document de référence ou de ses actualisations
Report Publication Announcement Classification · 99% confidence The document is a press release titled "Le Groupe Ipsen publie son Document de Référence 2015" (Ipsen Group publishes its 2015 Reference Document). It explicitly states that the 'Document de Référence 2015' (which often corresponds to a comprehensive annual filing like a 10-K or its local equivalent, containing the Annual Financial Report and governance information) has been filed with the AMF (Autorité des Marchés Financiers). Crucially, the document itself is short (3543 characters) and its primary function is to announce the publication and availability of the main report, rather than being the report itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which announces the release of a major document.
2016-03-31 French
Information relating to the total number of voting rights and shares making up the capital
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly information regarding the total number of voting rights and total number of shares of the Company' and explicitly references Article 223-16 of the AMF General Regulations. It provides a monthly update (February 29, 2016) on the total number of shares and voting rights. This specific type of regular disclosure regarding voting rights and share capital structure aligns most closely with a general regulatory announcement or a specific disclosure related to capital structure, but given the options, it is a specific regulatory disclosure. Since there is no specific code for 'Monthly Voting Rights Disclosure', and it is a formal regulatory notice concerning share capital/voting rights, it fits best under the general 'Regulatory Filings' (RNS) as a fallback, or potentially 'Share Issue/Capital Change' (SHA) if interpreted broadly. However, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is defined as 'Official results from shareholder votes at any general meeting'. This document is a monthly update on the *number* of rights, not the *results* of a vote. Given the nature of mandatory monthly disclosure on voting rights, RNS is the most appropriate general regulatory filing category when a more specific one (like DVA, which implies results of a meeting) does not fit perfectly. The document is short and is a direct disclosure, not an announcement of another report.
2016-03-07 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and voting rights as of a specific date (February 29, 2016). This content directly relates to the structure of the company's capital and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it is a mandatory periodic disclosure regarding the capital base, or potentially 'Regulatory Filings' (RNS) if a more specific category isn't available. However, since it details the composition of the capital and voting rights, SHA is the most precise fit among the provided options, as it concerns the share structure.
2016-03-07 French
Communicated under the obligation to provide permanent information / Other communications
Remuneration Information Classification · 98% confidence The document explicitly discusses the 'compensation of executive directors,' specifically detailing the fixed and variable compensation components for the Chairman and CEO, Mr. Marc de Garidel, for the years 2015 and 2016. This content directly aligns with the definition of Remuneration Information. The filing category DEF 14A (Proxy Solicitation & Information Statement, which often includes compensation details) is listed as 'Remuneration Information' in the provided definitions, which corresponds to the content focus. Although the document mentions the information will be in the Registration Document, the document itself is a specific disclosure about executive pay, making 'DEF 14A' the most appropriate classification based on the provided list, as it specifically covers compensation details.
2016-03-07 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Remuneration Information Classification · 98% confidence The document is titled "Information permanente relative à la rémunération des dirigeants mandataires sociaux" (Permanent information relating to the remuneration of executive officers) and explicitly details the fixed and variable compensation elements for the CEO, Marc de Garidel, for the years 2015 and 2016. This content directly aligns with the definition of Remuneration Information, which corresponds to the DEF 14A filing type (Proxy Statement/Information Statement detailing executive compensation in the US context, or equivalent disclosure in other jurisdictions). Although the document mentions that the full details will be in the 'Document de Référence' (Reference Document), this specific text is a direct disclosure of the remuneration figures themselves, making it a Remuneration Information document (DEF 14A). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K) as it focuses solely on executive pay structure and amounts.
2016-03-07 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Earnings Release Classification · 95% confidence The document is titled "Ipsen's 2015 results and 2016 financial objectives" and contains detailed financial tables comparing 2015 results to 2014, including sales, operating income, EPS, and cash flow. It also discusses performance against 2015 financial objectives and sets out 2016 financial objectives. This content strongly indicates a comprehensive report of financial performance for a completed period. Although it mentions the 'annual financial report' will be available on the website, the provided text itself contains the core results and management commentary, which aligns best with an Earnings Release (ER) or an Interim/Quarterly Report (IR) if the period was not the full year. Since the document covers the full year 2015 results and sets objectives for 2016, it functions as the primary announcement of annual results. Given the depth of the financial data presented immediately, it is more than just a brief 'Earnings Release' (ER) but less comprehensive than a full 10-K filing (which would typically include extensive footnotes and full regulatory statements). However, the structure—announcing results, providing tables, management commentary, and future outlook—is characteristic of a major periodic financial announcement. Since the document covers the full year (2015 results), it is the primary annual results announcement. If it were a 10-K, it would likely reference SEC filing requirements. Since it is a detailed announcement of annual results, it is classified as an Earnings Release (ER) or potentially an Interim Report (IR) if the company reports quarterly/half-yearly. Given the context of '2015 results' and '2016 objectives' for a full year, ER is the most appropriate fit for the initial, detailed announcement of annual performance highlights and figures, even though it is quite detailed. It is not a proxy statement (DEF 14A), a full annual report (10-K), or a simple announcement of a report (RPA). FY 2015
2016-03-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.